» Articles » PMID: 18505839

Contacts Between Membrane Proximal Regions of the PDGF Receptor Ectodomain Are Required for Receptor Activation but Not for Receptor Dimerization

Overview
Specialty Science
Date 2008 May 29
PMID 18505839
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

The mechanism of PDGF-receptor beta (PDGFRbeta) activation was explored by analyzing the properties of mutant receptors designed based on the crystal structure of the extracellular region of the related receptor tyrosine kinase KIT/stem cell factor receptor. Here, we demonstrate that PDGF-induced activation of a PDGFRbeta mutated in Arg-385 or Glu-390 in D4 (the fourth Ig-like domain of the extracellular region) was compromised, resulting in impairment of a variety of PDGF-induced cellular responses. These experiments demonstrate that homotypic D4 interactions probably mediated by salt bridges between Arg-385 and Glu-390 play an important role in activation of PDGFRbeta and all type III receptor tyrosine kinases. We also used a chemical cross-linking agent to covalently cross-link PDGF-stimulated cells to demonstrate that a Glu390Ala mutant of PDGFRbeta undergoes typical PDGF-induced receptor dimerization. However, unlike WT PDGFR that is expressed on the surface of ligand-stimulated cells in an active state, PDGF-induced Glu390Ala dimers are inactive. Although the conserved amino acids that are required for mediating D4 homotypic interactions are crucial for PDGFRbeta activation, these interactions are dispensable for PDGFRbeta dimerization. Moreover, PDGFRbeta dimerization is necessary but not sufficient for tyrosine kinase activation.

Citing Articles

PDGFRA K385 mutants in myxoid glioneuronal tumors promote receptor dimerization and oncogenic signaling.

de Villenfagne L, Sablon A, Demoulin J Sci Rep. 2024; 14(1):7204.

PMID: 38532028 PMC: 10965988. DOI: 10.1038/s41598-024-57859-5.


Cryo-EM analyses of KIT and oncogenic mutants reveal structural oncogenic plasticity and a target for therapeutic intervention.

Krimmer S, Bertoletti N, Suzuki Y, Katic L, Mohanty J, Shu S Proc Natl Acad Sci U S A. 2023; 120(13):e2300054120.

PMID: 36943885 PMC: 10068818. DOI: 10.1073/pnas.2300054120.


Glycan Modulation of Insulin-like Growth Factor-1 Receptor.

Boothello R, Sankaranarayanan N, Sistla J, Nagarajan B, Sharon C, Chittum J Angew Chem Int Ed Engl. 2022; 61(49):e202211320.

PMID: 36205924 PMC: 9712175. DOI: 10.1002/anie.202211320.


The emerging complexity of PDGFRs: activation, internalization and signal attenuation.

Rogers M, Fantauzzo K Biochem Soc Trans. 2020; 48(3):1167-1176.

PMID: 32369556 PMC: 7722362. DOI: 10.1042/BST20200004.


A novel sensitive assay for detection of a biomarker of pericyte injury in cerebrospinal fluid.

Sweeney M, Sagare A, Pachicano M, Harrington M, Joe E, Chui H Alzheimers Dement. 2020; 16(6):821-830.

PMID: 32301266 PMC: 7986963. DOI: 10.1002/alz.12061.


References
1.
Pawson T, Nash P . Assembly of cell regulatory systems through protein interaction domains. Science. 2003; 300(5618):445-52. DOI: 10.1126/science.1083653. View

2.
Andrews A, Balciunaite E, Leong F, Tallquist M, Soriano P, Refojo M . Platelet-derived growth factor plays a key role in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci. 1999; 40(11):2683-9. View

3.
Hubbard S . Structural analysis of receptor tyrosine kinases. Prog Biophys Mol Biol. 1999; 71(3-4):343-58. DOI: 10.1016/s0079-6107(98)00047-9. View

4.
Schlessinger J . Cell signaling by receptor tyrosine kinases. Cell. 2000; 103(2):211-25. DOI: 10.1016/s0092-8674(00)00114-8. View

5.
Cochet C, Kashles O, Chambaz E, Borrello I, King C, Schlessinger J . Demonstration of epidermal growth factor-induced receptor dimerization in living cells using a chemical covalent cross-linking agent. J Biol Chem. 1988; 263(7):3290-5. View